JAMP CALCIUM POLYSTYRENE SULFONATE
JAMP CALCIUM POLYSTYRENE SULFONATE
Dormant
DIN Number
02502631
Drug Class
Human
Market Date
May 2, 2022
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02502631
AIG Number0113563002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V03AE01 POLYSTYRENE SULPHONATE
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationOral
,
Rectal
AHFS Classification40:18.18
Health Canada Classification
ACTIVE INGREDIENTS (1)
CALCIUM POLYSTYRENE SULFONATEActive
Strength: 999 MG / G
Monograph: CALCIUM POLYSTYRENE SULFONATE